The Pathologist: Labs Embrace Rapid Testing to Address Antibiotic Resistance

Faster results lead to improved patient outcomes and lower healthcare costs A new article in The Pathologist reports on “The Race Against Resistance,” detailing how rapid molecular testing can be used in efforts to rein in the spread of antibiotic resistance. Authored by Sherry Dunbar, Luminex’s Senior Director of Global Scientific Affairs, the article offers […]

Read More…

Webinar: How a Community Hospital Saved $600,000 with Rapid Diagnostics

Rapid results help medical teams avoid unnecessary use of broad-spectrum antibiotics Rapid diagnostic testing is a critical component of successful antimicrobial stewardship programs, according to an expert from Blount Memorial Hospital in Maryville, Tennessee. In a recent webinar, Clinical Pharmacy Specialist Brad Crane shared his story of implementing rapid diagnostic testing at his non-teaching community […]

Read More…

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,” […]

Read More…

Find Us in Philly: AACC 2016

Breakthrough innovations in clinical testing and patient care

We’re looking forward to next week’s AACC Annual Scientific Meeting & Clinical Lab Expo, being held in Philadelphia from July 31st to August 4th. Organized by the American Association for Clinical Chemistry, AACC is one of the most important clinical lab mega-meetings, with thousands of attendees each year. We’re eager to join discussions about the latest in lab testing platforms and how automated solutions are making a difference in molecular screening.

[…]

Read More…

Elements to Include in Pharmacogenetic Reports

For a physician to effectively treat a patient, it is important to have a complete diagnostic overview of the individual such as physiological factors (age, sex, and pre-existing diseases), renal and liver function, environment factors (lifestyle, such as tobacco, alcohol use, and co-administered drugs), and pharmacogenetic information. The goal for the physician is to collect the […]

Read More…

At ECCMID 2016, All Eyes on Drug-Resistant Microbes

The Luminex® team was delighted to participate this month in one of the most important molecular diagnostic conferences: ECCMID, or the European Congress of Clinical Microbiology and Infectious Diseases. We were honored to have so many people visit the Luminex booth and enjoy our Experience Room, where they got to see firsthand how our FDA-cleared, CE marked IVD ARIES® System operates, learn about the CE marked NxTAG® Respiratory Pathogen Panel, and our new software solution, SYNCT™. […]

Read More…

Zika Virus Update: New Study Findings, Local Case Reports

New white paper available The mainstream news has certainly reduced its coverage of the Zika viral epidemic, but there’s still plenty happening that our community should be aware of. The Centers for Disease Control and Prevention (CDC) recently published results of a new study showing that Zika virus can replicate in placentas and in the […]

Read More…

ARIES® System Provides Excellent Sensitivity and Specificity for HSV 1&2 Testing

Mayo Clinic study compares ARIES® HSV 1&2 Assay with Roche and Hologic assays/platforms A new publication from scientists at the Mayo Clinic reports results of the first comparison of three automated molecular diagnostic platforms for detecting and differentiating herpes simplex virus types 1 and 2. We were pleased to see that the ARIES® System was […]

Read More…

In Indiana, Riverview Health Improves Patient Outcomes with the VERIGENE® System

Flexibility and targeted approach reduced costs and time to results At the recent South Central Association for Clinical Microbiology (SCACM) meeting, Ronald Reitenour, MT(ASCP), Area Coordinator Microbiology from Riverview Health in Noblesville, Indiana, presented results from his team’s experience with the VERIGENE® System and the impact the entire VERIGENE® infectious disease portfolio has made on […]

Read More…

Choosing an MDx Platform

Important factors to consider for meeting a community’s infectious disease needs Recently, clinical laboratories have seen a dramatic increase in the adoption of molecular diagnostic systems for infectious disease testing. These platforms support a laboratory’s need to generate clinically actionable data faster than ever before, compared to traditional methods, without compromising reliable performance. However, with […]

Read More…